Cybernet Data Systems Inc.
The Dow Chemical Company has announced the offering of a series of InterNotes, with three tranches available: 5.650% InterNotes due on November 15, 2028, 6.100% InterNotes due on November 15, 2033, and 6.700% InterNotes due on November 15, 2053. These InterNotes are senior unsecured notes that will
Cybernet Data Systems Inc.
Energy Transfer LP, a leading energy company, and Crestwood Equity Partners LP, a midstream master limited partnership, announced on November 1, 2023, the preliminary results of the election made by holders of Crestwood's outstanding 9.250% Perpetual Preferred Units regarding the form of merger consideration to be received
Cybernet Data Systems Inc.
Apollo Global Management, Inc. has reported financial results for the third quarter ended September 30, 2023. The company's CEO, Marc Rowan, stated that despite challenging market conditions, Apollo's business model has demonstrated resilience and growth characteristics. Apollo's leading Asset Management and Retirement Services franchises
Information technology services industry
Ball Corporation has reached an agreement to sell its aerospace business to BAE Systems for gross proceeds of $5.6 billion in cash. The transaction, which is subject to regulatory approvals and customary closing conditions and adjustments, is projected to close in the first half of 2024. The sale of
Information technology services industry
The Dow Chemical Company has announced the availability of certain tranches of its InterNotes, which are senior unsecured notes issued under its Debt Issuance Facility. The InterNotes are due on August 15, 2028, 2033, and 2053, with respective face values of $500,000, $203,000, and $2,117,000. The
Cybernet Data Systems Inc.
Yum! Brands, Inc. reported strong growth in its Q2 2023 earnings, exceeding projections despite headwinds from foreign currency translation and the impact of Russia's invasion on Ukraine. The company's system sales growth, same-store sales growth, and net new unit growth all showed significant improvement, driven by
Cybernet Data Systems Inc.
Clear Channel Outdoor Holdings, Inc.'s business is primarily driven by the sale of advertising space on out-of-home displays in various key markets. The company operates in four reportable business segments: America, Airports, Europe-North, and Europe-South. Macroeconomic trends, including gross domestic product changes, significantly impact the company's
Cybernet Data Systems Inc.
As a global financial services leader, Prudential Financial (PFI) has operations in the United States, Asia, Europe, and Latin America, with a diverse range of businesses including life insurance, annuities, retirement solutions, mutual funds, and investment management. In its Q2 2023 earnings report, PFI highlighted its proactive approach to managing
Cybernet Data Systems Inc.
The Dow Chemical Company has announced the release of new InterNotes, a type of senior unsecured note, with features that make them attractive to investment advisers and selected dealers. The notes have a semi-annual interest rate of 1.800% and 3.150%, respectively, and are callable at 100% of the
Information technology services industry
T-Mobile US, Inc., a major wireless communications service provider, has released its second quarter 2023 financial results, providing insight into the company's financial condition and operations. The report highlights key performance metrics, segmental information, and notes certain business and regulatory developments that may impact the company's
Information technology services industry
Linde plc, a leading industrial gases company, reported robust second quarter 2023 results, with adjusted operating profit increasing by 15% year-over-year to $2,643 million. The company's revenue grew 13% to $8,244 million, driven by higher pricing, productivity initiatives, and lower depreciation and amortization. Adjusted earnings per
Cybernet Data Systems Inc.
Zai Lab Limited and its partner argenx have announced the approval of VYVGART (efgartigimod alfa injection) by China's National Medical Products Administration for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. This approval marks a significant milestone in the
